Sharp Therapeutics Private Limited

Founded in 2011 and headquartered in Telangana, India.

2011 | Hyderabad, Telangana (India) | Inactive
Last Updated: February 01, 2024

Sharp Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 14 Year, 7 Days
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth %
  • Ebitda
  • Net Worth -6.34%
  • Total Assets %

About Sharp Therapeutics

Sharp Therapeutics Private Limited (STPL) is Strike Off company established on 18 Feb 2011 with its office registered at Hyderabad, Telangana, India and has been running since 14 Year, 7 Days with a paid up capital of 0.20 M. According to MCA records, 2 Directors are linked to this company as of 01 Feb 2024.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24100TG2011PTC072708

  • Company No.

    072708

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Feb 2011

  • Date of AGM

    30 Sep 2017

  • Date of Balance Sheet

    31 Mar 2017

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Chemicals

Who are the key members and board of directors at Sharp Therapeutics?

Board Members (2)

NameDesignationAppointment DateStatus
Bhaskar Atla Country flag representing In Director 18-Feb-2011Current
Satyanarayana Saladi Country flag representing In Director 18-Feb-2011Current

Financial Performance of Sharp Therapeutics.

Sharp Therapeutics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 6.34%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
-6.34%
EBITDA

What is the Ownership and Shareholding Structure of Sharp Therapeutics?

In 2017, Sharp Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Sharp Therapeutics?

Unlock and access historical data on people associated with Sharp Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sharp Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharp Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sharp Therapeutics

Recent activity within the organization

  • Annual General Meeting

    Sharp Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records.

    30 Sep 2017

  • Balance Sheet

    Sharp Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad.

    31 Mar 2017

  • Director Appointment

    Bhaskar Reddy Atla was appointed as a Director was appointed as a Director on 18 Feb 2011 & has been associated with this company since 14 years 7 days .

    18 Feb 2011

  • Director Appointment

    Satyanarayana Saladi was appointed as a Director was appointed as a Director on 18 Feb 2011 & has been associated with this company since 14 years 7 days .

    18 Feb 2011

  • Company Incorporation

    Sharp Therapeutics Private Limited was registered on 18 Feb 2011 with Roc Hyderabad & aged 14 years 7 days as per MCA records.

    18 Feb 2011

Frequently asked questions

  • Sharp Therapeutics Private Limited was incorporated on 18 Feb 2011.

  • The authorized share capital of Sharp Therapeutics Private Limited is ₹ 0.20 M and paid-up capital is ₹ 0.20 M.

  • Currently 2 directors are associated with Sharp Therapeutics Private Limited.

    • Bhaskar Reddy Atla
    • Satyanarayana Saladi
  • As per Ministry of Corporate Affairs (Mca), the registered address of Sharp Therapeutics Private Limited is 2-2-1118/1/8/K 1St Floor, Shivam Road, Hyderabad, Telangana, India, 500044.

  • The corporate identification number (CIN) of Sharp Therapeutics Private Limited is U24100TG2011PTC072708 and the company number is 072708 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2017 indicates that The net worth of Sharp Therapeutics Private Limited has experienced an downturn of -6.34%.

  • The most recent Balance Sheet for Sharp Therapeutics Private Limited was filed with the ROC on 31 Mar 2017.